Related Videos
New Trial for Rare Brain Lymphoma Open at Roswell Park
Roswell Park Comprehensive Cancer Center is one of four locations in the United States and Europe in which patients with relapsed or refractory non-Hodgkin lymphoma in their central nervous system can access a new clinical trial, led by ...
Diffuse Large B-cell Lymphoma & High-grade B-cell Lymphoma
A trio of panelists, including Francisco Hernandez-Ilizaliturri from Roswell Park, Kieron Dunleavy from MedStar Georgetown University and Joanna Rhodes from Rutgers Robert Wood Johnson Medical School, discuss updates in treating DLBCL and HGBLs.
First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park
Chimeric antigen receptor (CAR) T-cell therapy is emerging as an effective therapeutic strategy for patients with B-cell lymphoid cancers.
